In another retrospective cohort study, the molecular features of EGFR-mutated NSCLC observed in brain metastases differed from those of primary tumors, suggesting that certain brain metastasis clones can also result in systemic progressions [224]. Here, EGFR is linked to non-small cell lung carcinoma.